All Stories

  1. Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

    Article • Infection and Drug Resistance, October 2018, Dove Medical Press

    Ross McKinnon, Professor David Llewellyn Gordon

  2. Integrated care in cancer: What is it, how is it used and where are the gaps? A textual narrative literature synthesis

    Article • European Journal of Cancer Care, April 2017, Wiley

    Ross McKinnon

  3. Induction of UDP-Glucuronosyltransferase 2B15 Gene Expression by the Major Active Metabolites of Tamoxifen, 4-Hydroxytamoxifen and Endoxifen, in Breast Cancer Cells

    Article • Drug Metabolism and Disposition, March 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Ross McKinnon

  4. Induction of Human UDP-Glucuronosyltransferase 2B7 Gene Expression by Cytotoxic Anticancer Drugs in Liver Cancer HepG2 Cells

    Article • Drug Metabolism and Disposition, February 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Ross McKinnon

  5. Low-molecular-weight heparin biosimilars: potential implications for clinical practice

    Article • Internal Medicine Journal, May 2014, Wiley

    Ross McKinnon, Dr Vito Ferro

  6. Pharmacogenomics in a Global World: A Roadmap for Australia, Prospects and Challenges

    Article • Current Pharmacogenomics and Personalized Medicine, January 2014, Bentham Science Publishers

    Ross McKinnon